Interim Clinical Commissioning Policy and Clinical Guide: Antivirals or neutralising monoclonal antibodies for non-hospitalised patients with COVID-19

Date published: 16 December 2021

Last updated: 24 February 2022

Rapid Policy statement

Details

**Please note implementation dates of the below documents**

Documents

Effective from 24 February 2022 - Interim Clinical Commissioning Policy: Antivirals or neutralising monoclonal antibodies for non-hospitalised patients with COVID-19
PDF (449 KB)
Effective from 24 February 2022 - Clinical Guide for UK Interim Clinical Commissioning Policy: Therapies for symptomatic non-hospitalised patients with COVID-19
PDF (706 KB)

Help viewing documents

Back to top